A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
NEW YORK, Aug. 16, 2016 -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces financial results for the three and six...
NEW YORK, July 18, 2016 -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces that abstracts from two studies conducted in...
NEW YORK, July 7, 2016 -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers, announces that a review of clinical research treatment outcomes using Melphalan...
Unprecedented Progression Free and Overall Survival Observed in University Hospital Southampton Retrospective AnalysisNEW YORK, July 6, 2016 -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on treatment of primary...
Againsttheodds.eu Recognized for High Quality Consumer Health ContentNEW YORK, June 23, 2016 -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on treatment of primary and metastatic liver cancers, announces that the...
NEW YORK, June 15, 2016 -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces that data from a large single hospital...
Proceeds expected to fund operations through year-end 2017NEW YORK, June 7, 2016 -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver...
NEW YORK, June 1, 2016 -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces that the General and Digestive Surgery team...
NEW YORK, May 31, 2016 -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces that Company management will participate at...
NEW YORK, May 4, 2016 -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces financial results for the three months ended...